Literature DB >> 33048572

Lower self-efficacy and greater depressive symptoms predict greater failure to recover from a single lapse cigarette.

Christine Muench1, Elizabeth J Malloy2, Laura M Juliano1.   

Abstract

OBJECTIVE: Smoking reexposure after a quit attempt (i.e., lapse) increases relapse risk, but lapse recovery is possible. Using a 6-day analogue model of smoking cessation and lapse, this study tested the effect of a single lapse cigarette on the risk of subsequent smoking. Abstinence self-efficacy (ASE) and depressive symptoms (using the Center for Epidemiological Studies Depression Scale, CES-D) were also examined as hypothesized moderators of lapse recovery.
METHOD: After receiving cessation counseling and achieving 2 days of incentivized abstinence, 54 daily smokers (mean age: 41 years, 61% African American, 63% male) were randomly assigned to smoke 1 cigarette or to a no-lapse control condition. Participants were then offered monetary incentives to abstain for 3 more days and smoking was monitored.
RESULTS: Compared to the control condition, participants who experienced a lapse had a 2.5 times greater risk of smoking in the first 24 hours Furthermore, a lapse resulted in much greater risk of subsequent smoking compared to the control condition among individuals with lower postquit ASE scores (p = .044) and greater CES-D scores (p = .040).
CONCLUSIONS: These findings provide preliminary evidence that a single lapse cigarette after quitting plays a causal role in subsequent smoking and suggest that individuals with lower postquit ASE and greater depressive symptoms are less likely to recover from a lapse. Future research should investigate factors associated with lapse recovery and failure so that effective lapse-responsive strategies can be developed. Laboratory models provide an efficient and controlled method to examine such processes. (PsycInfo Database Record (c) 2020 APA, all rights reserved).

Entities:  

Mesh:

Year:  2020        PMID: 33048572      PMCID: PMC8278682          DOI: 10.1037/ccp0000605

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  37 in total

Review 1.  A learning theory perspective on lapse, relapse, and the maintenance of behavior change.

Authors:  M E Bouton
Journal:  Health Psychol       Date:  2000-01       Impact factor: 4.267

2.  Dynamic effects of self-efficacy on smoking lapses and relapse among adolescents.

Authors:  Rinka M P Van Zundert; Stuart G Ferguson; Saul Shiffman; Rutger C M E Engels
Journal:  Health Psychol       Date:  2010-05       Impact factor: 4.267

3.  The return to smoking: 1-year relapse trajectories among female smokers.

Authors:  Cynthia A Conklin; Kenneth A Perkins; Ashli J Sheidow; Bobby L Jones; Michele D Levine; Marsha D Marcus
Journal:  Nicotine Tob Res       Date:  2005-08       Impact factor: 4.244

4.  A preliminary investigation of rapid smoking as a lapse-responsive treatment for tobacco dependence.

Authors:  Laura M Juliano; Elisabeth J Houtsmuller; Maxine L Stitzer
Journal:  Exp Clin Psychopharmacol       Date:  2006-11       Impact factor: 3.157

5.  First lapses to smoking: within-subjects analysis of real-time reports.

Authors:  S Shiffman; J A Paty; M Gnys; J A Kassel; M Hickcox
Journal:  J Consult Clin Psychol       Date:  1996-04

6.  Lapse-induced surges in craving influence relapse in adult smokers: an experimental investigation.

Authors:  William G Shadel; Steven C Martino; Claude Setodji; Daniel Cervone; Katie Witkiewitz; Ellen Burke Beckjord; Deborah Scharf; Regina Shih
Journal:  Health Psychol       Date:  2011-09       Impact factor: 4.267

7.  Self-efficacy: toward a unifying theory of behavioral change.

Authors:  A Bandura
Journal:  Psychol Rev       Date:  1977-03       Impact factor: 8.934

8.  Cigarette smoking and the onset and persistence of depression among adults in the United States: 1994-2005.

Authors:  Jafar Bakhshaie; Michael J Zvolensky; Renee D Goodwin
Journal:  Compr Psychiatry       Date:  2014-10-23       Impact factor: 3.735

9.  Self-efficacy and smoking cessation: a meta-analysis.

Authors:  Chad J Gwaltney; Jane Metrik; Christopher W Kahler; Saul Shiffman
Journal:  Psychol Addict Behav       Date:  2009-03

10.  Varenicline improves mood and cognition during smoking abstinence.

Authors:  Freda Patterson; Christopher Jepson; Andrew A Strasser; James Loughead; Kenneth A Perkins; Ruben C Gur; Joseph M Frey; Steven Siegel; Caryn Lerman
Journal:  Biol Psychiatry       Date:  2008-10-08       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.